133 related articles for article (PubMed ID: 10458545)
1. Tumor markers in endometriosis.
Abrão MS; Podgaec S; Pinotti JA; de Oliveira RM
Int J Gynaecol Obstet; 1999 Jul; 66(1):19-22. PubMed ID: 10458545
[TBL] [Abstract][Full Text] [Related]
2. [The use of biochemical markers in diagnosis of endometriosis].
Nalbanski A; Kiurkchiev D
Akush Ginekol (Sofiia); 2008; 47(4):19-22. PubMed ID: 19230253
[TBL] [Abstract][Full Text] [Related]
3. The use of biochemical markers in the diagnosis of pelvic endometriosis.
Abrão MS; Podgaec S; Filho BM; Ramos LO; Pinotti JA; de Oliveira RM
Hum Reprod; 1997 Nov; 12(11):2523-7. PubMed ID: 9436699
[TBL] [Abstract][Full Text] [Related]
4. Elevation of CA 19-9 and chromogranin A, in addition to CA 125, are detectable in benign tumors in leiomyomas and endometriosis.
Tsao KC; Hong JH; Wu TL; Chang PY; Sun CF; Wu JT
J Clin Lab Anal; 2007; 21(3):193-6. PubMed ID: 17506483
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of CA-125 and soluble CD-23 in patients with pelvic endometriosis: a case-control study.
Ramos IM; Podgaec S; Abrão MS; Oliveira Rd; Baracat EC
Rev Assoc Med Bras (1992); 2012; 58(1):26-32. PubMed ID: 22392313
[TBL] [Abstract][Full Text] [Related]
6. Use of CA125 fluctuation during the menstrual cycle as a tool in the clinical diagnosis of endometriosis; a preliminary report.
Kafali H; Artuc H; Demir N
Eur J Obstet Gynecol Reprod Biol; 2004 Sep; 116(1):85-8. PubMed ID: 15294374
[TBL] [Abstract][Full Text] [Related]
7. Menstrual cycle dependent variability for serum tumor markers CEA, AFP, CA 19-9, CA 125 and CA 15-3 in healthy women.
Erbağci AB; Yilmaz N; Kutlar I
Dis Markers; 1999 Dec; 15(4):259-67. PubMed ID: 10689549
[TBL] [Abstract][Full Text] [Related]
8. Copeptin is associated with the severity of endometriosis.
Tuten A; Kucur M; Imamoglu M; Kaya B; Acikgoz AS; Yilmaz N; Ozturk Z; Oncul M
Arch Gynecol Obstet; 2014 Jul; 290(1):75-82. PubMed ID: 24488583
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of the neutrophil-to-lymphocyte ratio and the combination of serum CA-125 for stages III and IV endometriosis.
Yang H; Lang JH; Zhu L; Wang S; Sha GH; Zhang Y
Chin Med J (Engl); 2013; 126(11):2011-4. PubMed ID: 23769549
[TBL] [Abstract][Full Text] [Related]
10. Correlation of preoperative biomarkers with severity of adhesion in endometriosis.
Lee Y; Lee Y; Lee S; Jung S; Chon S
J Gynecol Obstet Hum Reprod; 2020 Jan; 49(1):101637. PubMed ID: 31520750
[TBL] [Abstract][Full Text] [Related]
11. Increased serum cancer antigen-125 is a marker for severity of deep endometriosis.
Santulli P; Streuli I; Melonio I; Marcellin L; M'Baye M; Bititi A; Borghese B; Lafay Pillet MC; Chapron C
J Minim Invasive Gynecol; 2015 Feb; 22(2):275-84. PubMed ID: 25446542
[TBL] [Abstract][Full Text] [Related]
12. Serum CA-125 in preoperative patients at high risk for endometriosis.
Cheng YM; Wang ST; Chou CY
Obstet Gynecol; 2002 Mar; 99(3):375-80. PubMed ID: 11864662
[TBL] [Abstract][Full Text] [Related]
13. The effect of endometriosis, cycle stage, lymphocyte suppression and pregnancy on CA-125 levels in peritoneal fluid and serum in baboons.
Falconer H; Bambra CS; Chai D; Cornillie FJ; Hill JA; D'Hooghe TM
Hum Reprod; 2005 Nov; 20(11):3033-8. PubMed ID: 16037112
[TBL] [Abstract][Full Text] [Related]
14. Comparative study between VEGF-A and CA-125 in diagnosis and follow-up of advanced endometriosis after conservative laparoscopic surgery.
Mohamed ML; El Behery MM; Mansour SA
Arch Gynecol Obstet; 2013 Jan; 287(1):77-82. PubMed ID: 22930151
[TBL] [Abstract][Full Text] [Related]
15. [Correlation between CA-125 marker with the presence and severity of pelvic endometriosis].
Bianchi M; Macaya R; Durruty G; Manzur A
Rev Med Chil; 2003 Apr; 131(4):367-72. PubMed ID: 12870230
[TBL] [Abstract][Full Text] [Related]
16. Serum prolactin and CA-125 levels as biomarkers of peritoneal endometriosis.
Bilibio JP; Souza CA; Rodini GP; Andreoli CG; Genro VK; de Conto E; Cunha-Filho JS
Gynecol Obstet Invest; 2014; 78(1):45-52. PubMed ID: 24861131
[TBL] [Abstract][Full Text] [Related]
17. Relevance of CA-125 in the evaluation of endometriosis.
Colacurci N; Fortunato N; De Franciscis P; Cardone A
Clin Exp Obstet Gynecol; 1996; 23(3):150-4. PubMed ID: 8894323
[TBL] [Abstract][Full Text] [Related]
18. Prediction of pelvic pathology in subfertile women with combined Chlamydia antibody and CA-125 tests.
Penninx J; Brandes M; de Bruin JP; Schneeberger PM; Hamilton CJ
Eur J Obstet Gynecol Reprod Biol; 2009 Dec; 147(2):178-82. PubMed ID: 19733956
[TBL] [Abstract][Full Text] [Related]
19. Serum HE4 concentration is not dependent on menstrual cycle or hormonal treatment among endometriosis patients and healthy premenopausal women.
Hallamaa M; Suvitie P; Huhtinen K; Matomäki J; Poutanen M; Perheentupa A
Gynecol Oncol; 2012 Jun; 125(3):667-72. PubMed ID: 22426487
[TBL] [Abstract][Full Text] [Related]
20. [Elevated level of CA 125 antigen in women in reproductive age without neoplastic diseases in pelvis minor].
Bulsa M; Nowacki M; Perzanowski P
Ginekol Pol; 2002 Jun; 73(6):517-22. PubMed ID: 12185716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
